Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Professional development

Tools & Techniques Analytical science

OCT for the People

| Adam Wax

Can a low-cost OCT device aid research and improve disease diagnosis in low-income settings?

Outside the Lab Drug delivery

The Cost of Treating Cancer

| Roisin McGuigan

When you crunch the numbers on drug development, are the costs of cancer drugs justified?

Outside the Lab Imaging

“May I Enjoy Life and Art”

| Ruth Steer

Research shows that art training can improve ophthalmologists’ observational skills.

Outside the Lab Personalized medicine

"Sexy" Needs Substance

| Rajesh Rao

We need to explain the context when using “grab bag” phrases in science and medicine

Outside the Lab Animal models

Pulling Back the Pre-Clinical Curtain

| William Aryitey

Are mouse models the best option we have?

Outside the Lab Public health

Change is Here, But Are We Ready For it?

| Giorgio Stanta

Patient-centric healthcare can only be fully achieved if we change the current organizational methods

Outside the Lab Public health

Accessing Big Pharma's Conscience

| Jayasree K. Iyer

Jayasree K. Iyer, Executive Director of Access to Medicine Foundation, the Netherlands

Outside the Lab Professional development

Speed Versus Safety for Cell Therapy

| Karen Nichols and Jacques Galipeau

We want faster translation of cell therapies, but is it worth sacrificing public trust?

Outside the Lab Drug discovery

Taking Cues from the City of Notions

| Chas Bountra

Boston leads the drug discovery field, and the UK could soon follow suit

Research Field Professional development

The Synthesizer

| Jef Boeke

Jef Boeke, Professor, Department of Biochemistry and Molecular Pharmacology at NYU

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register